Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 11

    1.

    Ability of VKORC1 and CYP2C9 to predict therapeutic warfarin dose during the initial weeks of therapy.

    Ferder N, Eby CS, Deych E, Harris JK, Ridker PM, Milligan P, Goldhaber SZ, King CR, Giri T, McLeod HL, Glynn RJ, Gage BF.

    J Thromb Haemost. 2009 Oct 30. [Epub ahead of print]PMID: 19874474 [PubMed - as supplied by publisher]Related articles

    2.

    BIO5192, a small molecule inhibitor of VLA-4, mobilizes hematopoietic stem and progenitor cells.

    Ramirez P, Rettig MP, Uy GL, Deych E, Holt MS, Ritchey JK, DiPersio JF.

    Blood. 2009 Aug 13;114(7):1340-3. Epub 2009 Jul 1.PMID: 19571319 [PubMed - indexed for MEDLINE]Related articles

    3.

    Anemia: an independent predictor of death and hospitalizations among elderly patients with atrial fibrillation.

    Sharma S, Gage BF, Deych E, Rich MW.

    Am Heart J. 2009 Jun;157(6):1057-63. Epub 2009 Apr 25.PMID: 19464417 [PubMed - indexed for MEDLINE]Related articles

    4.

    Laboratory and clinical outcomes of pharmacogenetic vs. clinical protocols for warfarin initiation in orthopedic patients.

    Lenzini PA, Grice GR, Milligan PE, Dowd MB, Subherwal S, Deych E, Eby CS, King CR, Porche-Sorbet RM, Murphy CV, Marchand R, Millican EA, Barrack RL, Clohisy JC, Kronquist K, Gatchel SK, Gage BF.

    J Thromb Haemost. 2008 Oct;6(10):1655-62. Epub 2008 Jul 24.PMID: 18662264 [PubMed - indexed for MEDLINE]Related articles

    5.

    Use of pharmacogenetic and clinical factors to predict the therapeutic dose of warfarin.

    Gage BF, Eby C, Johnson JA, Deych E, Rieder MJ, Ridker PM, Milligan PE, Grice G, Lenzini P, Rettie AE, Aquilante CL, Grosso L, Marsh S, Langaee T, Farnett LE, Voora D, Veenstra DL, Glynn RJ, Barrett A, McLeod HL.

    Clin Pharmacol Ther. 2008 Sep;84(3):326-31. Epub 2008 Feb 27. Erratum in: Clin Pharmacol Ther. 2008 Sep;84(3):430. PMID: 18305455 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Optimal initial dose adjustment of warfarin in orthopedic patients.

    Lenzini PA, Grice GR, Milligan PE, Gatchel SK, Deych E, Eby CS, Burnett RS, Clohisy JC, Barrack RL, Gage BF.

    Ann Pharmacother. 2007 Nov;41(11):1798-804. Epub 2007 Oct 2.PMID: 17911206 [PubMed - indexed for MEDLINE]Related articles

    7.

    Genetic-based dosing in orthopedic patients beginning warfarin therapy.

    Millican EA, Lenzini PA, Milligan PE, Grosso L, Eby C, Deych E, Grice G, Clohisy JC, Barrack RL, Burnett RS, Voora D, Gatchel S, Tiemeier A, Gage BF.

    Blood. 2007 Sep 1;110(5):1511-5. Epub 2007 Mar 26.PMID: 17387222 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Improving organochlorine biomarker models for cancer research.

    Wolff MS, Britton JA, Teitelbaum SL, Eng S, Deych E, Ireland K, Liu Z, Neugut AI, Santella RM, Gammon MD.

    Cancer Epidemiol Biomarkers Prev. 2005 Sep;14(9):2224-36.PMID: 16172236 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Predictors of organochlorines in New York City pregnant women, 1998-2001.

    Wolff MS, Deych E, Ojo F, Berkowitz GS.

    Environ Res. 2005 Feb;97(2):170-7.PMID: 15533333 [PubMed - indexed for MEDLINE]Related articles

    10.

    Integrated pest management in an urban community: a successful partnership for prevention.

    Brenner BL, Markowitz S, Rivera M, Romero H, Weeks M, Sanchez E, Deych E, Garg A, Godbold J, Wolff MS, Landrigan PJ, Berkowitz G.

    Environ Health Perspect. 2003 Oct;111(13):1649-53.PMID: 14527845 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Exposure to indoor pesticides during pregnancy in a multiethnic, urban cohort.

    Berkowitz GS, Obel J, Deych E, Lapinski R, Godbold J, Liu Z, Landrigan PJ, Wolff MS.

    Environ Health Perspect. 2003 Jan;111(1):79-84.PMID: 12515682 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data

    Search details

    » See more...